Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hayden

Showing results (521-530 of 538) with videos related to

Pageof 54
Sort By:
European Journal of Haematology|November 19, 2019
Conditioning-based outcomes after allogeneic transplantation for myeloma following a prior autologous transplant (1991-2012) on behalf of EBMT CMWPPatrick J Hayden, Simona Iacobelli, José Antonio Pérez-Simón, et al.
Haematologica|November 23, 2019
Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)Ibrahim Yakoub-Agha, Christian Chabannon, Peter Bader, et al.
Bone Marrow Transplantation|January 21, 2023
Safety and efficacy of autologous stem cell transplantation in dialysis-dependent myeloma patients-The DIADEM study from the chronic malignancies working party of the EBMTAnna Waszczuk-Gajda, Luuk Gras, Liesbeth C de Wreede, et al.
Molecular Endocrinology (Baltimore, Md.)|December 17, 2011
A SNP in steroid receptor coactivator-1 disrupts a GSK3β phosphorylation site and is associated with altered tamoxifen response in boneR J Hartmaier, A S Richter, R M Gillihan, et al.
Nature Communications|February 12, 2022
Genomic variants affecting homoeologous gene expression dosage contribute to agronomic trait variation in allopolyploid wheatFei He, Wei Wang, William B Rutter, et al.
Bone Marrow Transplantation|May 12, 2021
Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working PartyPatrick J Hayden, Dirk-Jan Eikema, Liesbeth C de Wreede, et al.
American Journal of Hematology|February 8, 2022
Phase 2 studies of lenalidomide, subcutaneous bortezomib, and dexamethasone as induction therapy in patients with newly diagnosed multiple myelomaPeter O'Gorman, Jacob P Laubach, Michael E O'Dwyer, et al.
British Journal of Haematology|April 5, 2024
Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph+ chronic myeloid leukaemia: A retrospective analysis from the Chronic Malignancies Working Party of the EBMTFrancesco Onida, Luuk Gras, Junran Ge, et al.
Bone Marrow Transplantation|March 28, 2023
The European landscape on allogeneic haematopoeietic cell transplantation in Chronic Lymphocytic Leukaemia between 2009 and 2019: a perspective from the Chronic Malignancies Working Party of the EBMTOlivier Tournilhac, Michel van Gelder, Dirk-Jan Eikema, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2013
Genome-wide comparative diversity uncovers multiple targets of selection for improvement in hexaploid wheat landraces and cultivarsColin R Cavanagh, Shiaoman Chao, Shichen Wang, et al.
Pageof 54

Showing results (521-530 of 538) with videos related to

Sort By:
Pageof 54
European Journal of Haematology|November 19, 2019
Conditioning-based outcomes after allogeneic transplantation for myeloma following a prior autologous transplant (1991-2012) on behalf of EBMT CMWPPatrick J Hayden, Simona Iacobelli, José Antonio Pérez-Simón, et al.
Haematologica|November 23, 2019
Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)Ibrahim Yakoub-Agha, Christian Chabannon, Peter Bader, et al.
Bone Marrow Transplantation|January 21, 2023
Safety and efficacy of autologous stem cell transplantation in dialysis-dependent myeloma patients-The DIADEM study from the chronic malignancies working party of the EBMTAnna Waszczuk-Gajda, Luuk Gras, Liesbeth C de Wreede, et al.
Molecular Endocrinology (Baltimore, Md.)|December 17, 2011
A SNP in steroid receptor coactivator-1 disrupts a GSK3β phosphorylation site and is associated with altered tamoxifen response in boneR J Hartmaier, A S Richter, R M Gillihan, et al.
Nature Communications|February 12, 2022
Genomic variants affecting homoeologous gene expression dosage contribute to agronomic trait variation in allopolyploid wheatFei He, Wei Wang, William B Rutter, et al.
Bone Marrow Transplantation|May 12, 2021
Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working PartyPatrick J Hayden, Dirk-Jan Eikema, Liesbeth C de Wreede, et al.
American Journal of Hematology|February 8, 2022
Phase 2 studies of lenalidomide, subcutaneous bortezomib, and dexamethasone as induction therapy in patients with newly diagnosed multiple myelomaPeter O'Gorman, Jacob P Laubach, Michael E O'Dwyer, et al.
British Journal of Haematology|April 5, 2024
Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph+ chronic myeloid leukaemia: A retrospective analysis from the Chronic Malignancies Working Party of the EBMTFrancesco Onida, Luuk Gras, Junran Ge, et al.
Bone Marrow Transplantation|March 28, 2023
The European landscape on allogeneic haematopoeietic cell transplantation in Chronic Lymphocytic Leukaemia between 2009 and 2019: a perspective from the Chronic Malignancies Working Party of the EBMTOlivier Tournilhac, Michel van Gelder, Dirk-Jan Eikema, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2013
Genome-wide comparative diversity uncovers multiple targets of selection for improvement in hexaploid wheat landraces and cultivarsColin R Cavanagh, Shiaoman Chao, Shichen Wang, et al.
Pageof 54